MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-28-0031476
Physa Pharmaceuticals Private Limited
Physa Pharmaceuticals Private Limited - chemicals in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹70.69 Lakh
▲ 8% YoY
Net profit · FY 2025
₹69,706
Net margin 1%
EBITDA · FY 2025
₹1.04 Lakh
EBITDA margin 1.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Physa Pharmaceuticals Private Limited
Data last updated:
Physa Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2019PTC122896. Its GSTIN is 09AAKCP8495R1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prins Kumar and Harpal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Noida, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.69 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹69,706 (net margin 1%) and EBITDA of ₹1.04 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 74% over five years.
Physa Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0031476). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230UP2019PTC122896
Registration Number 122896
Incorporation Date 31 October 2019
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0031476
Recognitions & Rankings of Physa Pharmaceuticals
Contact details
Physa Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressNear Harish Water Vill – Salarpur, House No – 97, Noida, Uttar Pradesh, India – 201305
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Physa Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Physa Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Physa Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Physa Pharmaceuticals Private Limited, buy the company report.
Financials of Physa Pharmaceuticals Private Limited
FY 2025 filings availablePhysa Pharmaceuticals Private Limited reported revenue of ₹70.69 Lakh (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹70.69 Lakh ▲ 8%
Net profit · FY 2025
₹69,706 margin 1%
EBITDA · FY 2025
₹1.04 Lakh margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 31%
5 years · compounded
▲ 74%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▼ 5%
5 years · compounded
▲ 73%
Revenue has grown at a compounded annual rate (CAGR) of 74% over five years, including 8% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹69,706 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Physa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Physa Pharmaceuticals Private Limited
Physa Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Kumar Also directs: Vopo Cable Private Limited | Additional Director | 03 May 2023 | 3 Years 6 Months | Current |
| Prins Kumar Also directs: Pas Health Foundation | Director | 31 Oct 2019 | 7 Years 0 Months | Current |
| Harpal | Director | 24 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Physa Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vizag Pharmaceuticals Private Limited | ₹70.81 Lakh (FY 2016) | -52.0% | Hyderabad, Telangana, India | |||
| Ecstatic Pharmaceuticals Private Limited | ₹70.76 Lakh (FY 2023) | 13.0% | Thane, Maharashtra, India | |||
| Physa Pharmaceuticals Private Limitedthis company | ₹70.69 Lakh (FY 2025) | ₹69,706 | 1% | 8.0% | Noida, Uttar Pradesh, India | |
| Hahnemann Pharmaceuticals Private Limited | ₹70.46 Lakh (FY 2024) | 28.0% | New Delhi, Delhi, India |
To see the full peer comparison of Physa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Physa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Physa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Physa Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCP8495R1Z1 | Uttar Pradesh | Active | 06 Aug 2022 |
To see the full GST registrations and return filing status of Physa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Physa Pharmaceuticals Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Sumit Kumar was appointed as Additional Director on 03 May 2023.
AGM
Physa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Physa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Sumit Kumar was appointed as Additional Director.
Appointed
Harpal was appointed as Director.
Ceased
Himanshu Verma ceased to be Additional Director.
Ceased
Hariom Shankar ceased to be Director.
Appointed
Prins Kumar was appointed as Director.
Incorporation
31 Oct 2019
Physa Pharmaceuticals Private Limited was registered on 31 Oct 2019 with Roc Kanpur & aged 7 years 10 days as per MCA records.
Frequently asked questions
Physa Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 October 2019 (7+ years old) and is registered under CIN U24230UP2019PTC122896.
Physa Pharmaceuticals has 3 current directors:
- Sumit Kumar - Additional Director
- Prins Kumar - Director
- Harpal - Director
The latest financial statements of Physa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Physa Pharmaceuticals is 09AAKCP8495R1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Physa Pharmaceuticals is U24230UP2019PTC122896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Physa Pharmaceuticals was incorporated on 31 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Physa Pharmaceuticals by revenue are Vizag Pharmaceuticals Private Limited, Ecstatic Pharmaceuticals Private Limited, Hahnemann Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sumit Kumar was appointed as Additional Director on 03 May 2023. Harpal was appointed as Director on 24 Jun 2022. Himanshu Verma ceased to be Additional Director on 24 Jun 2022. Physa Pharmaceuticals has 5 board changes on record in total.
Yes, Physa Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0031476).
The registered office of Physa Pharmaceuticals is at Near Harish Water Vill – Salarpur, House No – 97, Noida, Uttar Pradesh, India – 201305.
Physa Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages